Shimoda K, Noguchi T, Ozeki Y, Morita S, Shibasaki M, Someya T, Takahashi S
Department of Psychiatry, Shiga University of Medical Science, Japan.
Neuropsychopharmacology. 1995 Jul;12(4):323-33. doi: 10.1016/0893-133X(94)00098-K.
We measured the concentrations of clomipramine and its metabolites, N-desmethylclomipramine, 8-hydroxy-N-desmethylclomipramine, 8-hydroxyclomipramine by high-performance liquid chromatography in 108 Japanese psychiatric patients receiving clomipramine hydrochloride PO. The concentrations of the glucuronide conjugates of 8-hydroxyclomipramine and 8-hydroxy-N-desmethylclomipramine were assayed via enzymatic hydrolysis. Although there were large interindividual variations of concentrations of parent, intermediate metabolic compounds, and glucuronide conjugates, significant positive correlations were observed between these drug concentrations and daily doses of clomipramine hydrochloride (mg/kg body weight). Although the metabolic ratios for desmethylation, hydroxylation, and glucuronidation that were calculated from steady-state drug concentrations varied substantially with 36-, 14-, and 28-fold interindividual variations, respectively, apparent poor desmethylators, poor hydroxylators, or poor glucuronidators were not found.
我们采用高效液相色谱法,对108例口服盐酸氯米帕明的日本精神病患者体内的氯米帕明及其代谢产物N-去甲基氯米帕明、8-羟基-N-去甲基氯米帕明、8-羟基氯米帕明的浓度进行了测定。8-羟基氯米帕明和8-羟基-N-去甲基氯米帕明的葡萄糖醛酸结合物浓度通过酶水解法进行测定。尽管母体药物、中间代谢化合物及葡萄糖醛酸结合物的浓度存在较大的个体间差异,但这些药物浓度与盐酸氯米帕明的日剂量(mg/kg体重)之间存在显著的正相关。虽然根据稳态药物浓度计算出的去甲基化、羟基化和葡萄糖醛酸化的代谢率个体间差异很大,分别为36倍、14倍和28倍,但未发现明显的去甲基化不良者、羟基化不良者或葡萄糖醛酸化不良者。